Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells.
about
Microbial symbionts accelerate wound healing via the neuropeptide hormone oxytocinTGF-β2 suppresses macrophage cytokine production and mucosal inflammatory responses in the developing intestineEmerging roles of lactic acid bacteria in protection against colorectal cancerThe role of probiotic lactic acid bacteria and bifidobacteria in the prevention and treatment of inflammatory bowel disease and other related diseases: a systematic review of randomized human clinical trialsRegulatory T-cells: diverse phenotypes integral to immune homeostasis and suppressionProbiotics modulate intestinal expression of nuclear receptor and provide counter-regulatory signals to inflammation-driven adipose tissue activationComparison of microbiological, histological, and immunomodulatory parameters in response to treatment with either combination therapy with prednisone and metronidazole or probiotic VSL#3 strains in dogs with idiopathic inflammatory bowel diseaseInduction of colonic regulatory T cells by indigenous Clostridium speciesThe gut microbiota shapes intestinal immune responses during health and diseaseA key role of dendritic cells in probiotic functionality.Probiotics and necrotizing enterocolitis: finding the missing pieces of the probiotic puzzle.Commensal-induced regulatory T cells mediate protection against pathogen-stimulated NF-kappaB activation.Post-translational inhibition of IP-10 secretion in IEC by probiotic bacteria: impact on chronic inflammation.Oral probiotic control skin inflammation by acting on both effector and regulatory T cells.Review article: probiotics and prebiotics in irritable bowel syndrome.Effect of probiotics on clinical and immune parameters in enthesitis-related arthritis category of juvenile idiopathic arthritis.Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacyA novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells.Yeast modulation of human dendritic cell cytokine secretion: an in vitro study.The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis.The Probiotic Compound VSL#3 Modulates Mucosal, Peripheral, and Systemic Immunity Following Murine Broad-Spectrum Antibiotic Treatment.Microbial control of regulatory and effector T cell responses in the gut.Role of the microbiota in immunity and inflammation.Lactobacillus plantarum MB452 enhances the function of the intestinal barrier by increasing the expression levels of genes involved in tight junction formationCancer inflammation and regulatory T cells.Microbes in gastrointestinal health and diseaseProbiotics-host communication: Modulation of signaling pathways in the intestine.Anti-inflammatory effects of Lactococcus lactis NCDO 2118 during the remission period of chemically induced colitis.Immune response to Bifidobacterium bifidum strains support Treg/Th17 plasticity.IL-10 and TGF-beta redundantly protect against severe liver injury and mortality during acute schistosomiasisThe lactic acid bacterium Pediococcus acidilactici suppresses autoimmune encephalomyelitis by inducing IL-10-producing regulatory T cellsRecombinant probiotic expressing Listeria adhesion protein attenuates Listeria monocytogenes virulence in vitro.The interplay between the gut microbiota and the immune system.Modulation of antibody-mediated immune response by probiotics in chickens.Bifidobacteria-host interactions--an update on colonisation factors.Safety and protective effectiveness of two strains of Lactobacillus with probiotic features in an experimental model of salmonellosisFunctional heterologous protein expression by genetically engineered probiotic yeast Saccharomyces boulardii.Safety assessment of probiotics for human use.Probiotic bacteria induce a 'glow of health'Anti-inflammatory effects of probiotic yogurt in inflammatory bowel disease patients.
P2860
Q21132448-E5D1B7CD-2721-4B8D-905D-2A9F92D4A7ADQ24301263-DAB04BD7-AA9C-4E66-B891-0B8FFE2F82E5Q24563783-7A293596-D11C-4C43-8B1C-5A9A5C827F6AQ27001546-AF81FAC4-C372-4E28-9610-D88F7E2F44CDQ27022973-9DAD8F72-846B-4337-881E-6F78BC8BC59EQ27327276-3E3853A5-5C98-4FE3-BFC9-C4CE761CA4F4Q28537737-C6AD086D-ECA4-4924-9390-7F5B24393814Q29547701-678ECBCB-9AF5-469A-A7E6-9F4838757481Q29547727-7FF07FBE-84C8-47F6-B37C-3898475587F7Q30830505-4795E4CB-E839-4B0F-A042-9F56D15AD6C1Q33355303-F0B9D1FE-DBC9-4601-95E5-F5813A29BE88Q33356616-B42F1191-7CC7-4C2B-99F0-FBF23E74854CQ33406281-0C6B6C17-601E-4810-A725-9FE6429FCA88Q33419855-E51E81E2-46B0-481E-87CD-E04D1CEF0D33Q33440014-34806A6D-331E-4898-A83B-DDD88DDEC28BQ33468052-E33F9EC6-9277-40A5-AC6E-2B6B6CD4E179Q33503647-61CBC563-6D50-404B-8DA4-89CDC16D5D42Q33528981-31C94E78-1A92-4091-8001-A0A599A8E804Q33590266-1E66C9B5-F53B-4972-BC2C-C7083F6AE404Q33594436-56466FFF-5906-4049-8BFE-62E9424E7D9CQ33639134-7CBEFEA9-C23B-4E39-97EB-D2903A0D4844Q33699119-09401077-12FB-452C-984F-859A493AF581Q33752553-1498C4B2-360F-4D21-ADE7-84E721D4D23CQ33767034-4C16F2EB-295A-45A4-A3AA-AF353F85BECBQ33796582-FB75D7B7-20A1-48C0-9833-FD5DF5645AE9Q33943525-9EB4A93B-E2A7-411E-843B-FD434A1EADC2Q34018028-A0A7F7EA-639F-47ED-AE23-AB0516049F8FQ34018620-C4DBAD67-DB98-4F8C-8BDF-BBF7C5A75122Q34037796-3479E995-514A-4E68-A977-9CFC6FC3F216Q34064182-0682E1A5-111B-4375-8142-8695B34C71C9Q34081672-5BF6BEFE-FF2C-4A0A-945F-CDA5C13C5A8FQ34123613-F1A37A2F-F836-4751-8436-8F75DCC5C534Q34129422-D89A58CA-E36F-4431-BB61-08C3E7C21160Q34231240-DCAEC8DB-3828-4188-ADAC-88BD502FE421Q34256838-6A1D0E1F-AE9D-43C9-A92F-A3B2409A19FDQ34348003-AFB6A09D-228E-4CA1-8CB1-847A62D639C7Q34497819-006E8924-6A93-4138-817E-7F7FEC9CA4E4Q34503589-D338B19E-39C1-4D9A-B687-428B210B9148Q34558845-5F79FFED-56D4-4FAB-823A-A66A12C2D1F8Q34580564-AB5A3069-820F-42C5-8F8A-E96BDE916B2D
P2860
Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Probiotics ameliorate recurren ...... beta-bearing regulatory cells.
@en
Probiotics ameliorate recurren ...... beta-bearing regulatory cells.
@nl
type
label
Probiotics ameliorate recurren ...... beta-bearing regulatory cells.
@en
Probiotics ameliorate recurren ...... beta-bearing regulatory cells.
@nl
prefLabel
Probiotics ameliorate recurren ...... beta-bearing regulatory cells.
@en
Probiotics ameliorate recurren ...... beta-bearing regulatory cells.
@nl
P2093
P1476
Probiotics ameliorate recurren ...... beta-bearing regulatory cells.
@en
P2093
Claudia Di Giacinto
Mariarosaria Marinaro
Massimo Sanchez
Monica Boirivant
Warren Strober
P304
P356
10.4049/JIMMUNOL.174.6.3237
P407
P577
2005-03-01T00:00:00Z